Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Jun 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$118K
Net Open-Market Flow
-$118K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)10K$4.14$41K18K
Jun 23, 2026Sell(S)10K$12.00$118K9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)10K—$064K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001920738-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML